A saliva test for endometriosis providing a reliable diagnosis within just a few days
Where to find
Ziwig Endotest® ?
Europe
1
Finlande (Life Genomics) Mr Göran Jacobsson – +46 708-112 152 goran.jacobsson@lifegenomics.se
2
Suède (Life Genomics) Mr Göran Jacobsson – +46 708-112 152 goran.jacobsson@lifegenomics.se
3
Norvège (Life Genomics) Mr Göran Jacobsson – +46 708-112 152 goran.jacobsson@lifegenomics.se
7
Germany (Doctor Box) Mr Julian Maar info@doctorbox.de
9
Suisse (Labor Team W) +41 71 844 45 45 info@team-w.ch
10
Italie (Genomica Lab) Mrs Emanuela Rizzo marketing@genomicalab.it
13
Roumanie (Regina Maria)
Middle East
2
Arabie Saoudite (Tamer)
3
Israël (Tzamal) +972 52 720 1866 info@endotest.co.il
4
Jordanie (Safadi Drugstore)
5
Arménie (Eurolab) Mrs Sona Galstyan – +374 33 212104 s.galstyan@eurolab.am
ASIA
1
Inde (Precision woman’s care and research institute Pvt Ltd)
Americas
1
Brésil (College Pesquisa Clínica)
Together, let’s usher in a new era in the diagnosis of endometriosis, marked by scientific innovation and precision, to improve patient care.
I am interested in
Ziwig Endotest®
Omnigene Oral is an in vitro diagnostic device for the collection and stabilisation of nucleic acids in saliva. Manufacturer of the Omnigene Oral collection IVDD: DNA Genotek Inc. Read the enclosed leaflet carefully. Updated: 09/2024
- Ziwig Endotest® is an in vitro diagnostic device for professional use in the diagnosis of endometriosis using a saliva sample.
- Ziwig Endotest® is an innovative diagnostic method using salivary miRNA analysis to identify phenotypic profiles characteristic of endometriosis identified by NGS (next-generation sequencing) and modelled by AI.
- This in vitro diagnostic medical device is a regulated health product which, in accordance with these regulations, bears the CE mark.
Please read the information supplied with Ziwig Endotest® carefully. Manufacturer: Ziwig. Last update : 09/2024 - Ziwig Endotest® has obtained CE certification from a notified body (2797).
Stay connected
Sign up to be notified of the latest news and publications.